Maximus (NYSE:MMS) Sets New 1-Year Low – What’s Next?

Maximus, Inc. (NYSE:MMS – Get Free Report) reached a new 52-week low during mid-day trading on Thursday. The stock traded as low as $52.73 and last traded at $52.5850, with a volume of 82437 shares. The stock had previously closed at $53.79.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on MMS shares. Zacks Research downgraded shares of Maximus from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a report on Monday, August 17th. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Maximus presently has a consensus rating of “Reduce”.

Get Our Latest Research Report on Maximus

Maximus Stock Performance

The company has a 50-day simple moving average of $57.80 and a two-hundred day simple moving average of $61.02. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The firm has a market cap of $2.76 billion, a PE ratio of 7.79 and a beta of 0.59.

Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.01. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business’s revenue was down 5.1% compared to the same quarter last year. During the same period last year, the firm posted $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, equities research analysts forecast that Maximus, Inc. will post 8.03 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Friday, August 14th. Maximus’s dividend payout ratio (DPR) is 19.50%.

Institutional Trading of Maximus

Several hedge funds have recently added to or reduced their stakes in MMS. BlackRock Inc. bought a new position in shares of Maximus during the 2nd quarter valued at approximately $400,186,000. Reinhart Partners LLC. raised its holdings in shares of Maximus by 131.8% in the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock worth $106,575,000 after purchasing an additional 1,127,346 shares during the period. Norges Bank purchased a new position in Maximus in the fourth quarter valued at approximately $60,393,000. Bank of America Corp DE purchased a new position in Maximus in the second quarter valued at approximately $31,487,000. Finally, River Road Asset Management LLC lifted its stake in Maximus by 236.1% in the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock valued at $71,064,000 after purchasing an additional 578,326 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

(Get Free Report)

Maximus, Inc (NYSE: MMS) is a provider of technology-enabled government services. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and help agencies manage complex operational and administrative needs.

Its services include health and human services administration, employment and workforce support, program eligibility and enrollment, citizen engagement, customer contact centers, consulting and digital transformation.

Further Reading

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.